217 related articles for article (PubMed ID: 1368889)
1. Kinetic analysis of recombinant antibody-antigen interactions: relation between structural domains and antigen binding.
Borrebaeck CA; Malmborg AC; Furebring C; Michaelsson A; Ward S; Danielsson L; Ohlin M
Biotechnology (N Y); 1992 Jun; 10(6):697-8. PubMed ID: 1368889
[TBL] [Abstract][Full Text] [Related]
2. Interaction between the antigen and antibody is controlled by the constant domains: normal mode dynamics of the HEL-HyHEL-10 complex.
Adachi M; Kurihara Y; Nojima H; Takeda-Shitaka M; Kamiya K; Umeyama H
Protein Sci; 2003 Oct; 12(10):2125-31. PubMed ID: 14500870
[TBL] [Abstract][Full Text] [Related]
3. The crystal structures of complexes formed between lysozyme and antibody fragments.
Bentley GA
EXS; 1996; 75():301-19. PubMed ID: 8765306
[TBL] [Abstract][Full Text] [Related]
4. The effect of water activity on the association constant and the enthalpy of reaction between lysozyme and the specific antibodies D1.3 and D44.1.
Goldbaum FA; Schwarz FP; Eisenstein E; Cauerhff A; Mariuzza RA; Poljak RJ
J Mol Recognit; 1996; 9(1):6-12. PubMed ID: 8723314
[TBL] [Abstract][Full Text] [Related]
5. Comparative properties of the single chain antibody and Fv derivatives of mAb 4-4-20. Relationship between interdomain interactions and the high affinity for fluorescein ligand.
Mallender WD; Carrero J; Voss EW
J Biol Chem; 1996 Mar; 271(10):5338-46. PubMed ID: 8621386
[TBL] [Abstract][Full Text] [Related]
6. Real-time biospecific interaction analysis of a natural human polyreactive monoclonal IgM antibody and its Fab and scFv fragments with several antigens.
Roggenbuck D; König H; Niemann B; Schoenherr G; Jahn S; Porstmann T
Scand J Immunol; 1994 Jul; 40(1):64-70. PubMed ID: 8029645
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional structures of the free and antigen-bound Fab from monoclonal antilysozyme antibody HyHEL-63(,).
Li Y; Li H; Smith-Gill SJ; Mariuzza RA
Biochemistry; 2000 May; 39(21):6296-309. PubMed ID: 10828942
[TBL] [Abstract][Full Text] [Related]
8. The antigen-binding domain of a human IgG-anti-F(ab')2 autoantibody.
Welschof M; Terness P; Kipriyanov SM; Stanescu D; Breitling F; Dörsam H; Dübel S; Little M; Opelz G
Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1902-7. PubMed ID: 9050877
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of the complex of the variable domain of antibody D1.3 and turkey egg white lysozyme: a novel conformational change in antibody CDR-L3 selects for antigen.
Braden BC; Fields BA; Ysern X; Goldbaum FA; Dall'Acqua W; Schwarz FP; Poljak RJ; Mariuzza RA
J Mol Biol; 1996 Apr; 257(5):889-94. PubMed ID: 8632472
[TBL] [Abstract][Full Text] [Related]
10. Novel selection method for engineered antibodies using the mechanism of Fv fragment stabilization in the presence of antigen.
Tsumoto K; Nishimiya Y; Kasai N; Ueda H; Nagamune T; Ogasahara K; Yutani K; Tokuhisa K; Matsushima M; Kumagai I
Protein Eng; 1997 Nov; 10(11):1311-8. PubMed ID: 9514120
[TBL] [Abstract][Full Text] [Related]
11. "Diabodies": small bivalent and bispecific antibody fragments.
Holliger P; Prospero T; Winter G
Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6444-8. PubMed ID: 8341653
[TBL] [Abstract][Full Text] [Related]
12. Small rearrangements in structures of Fv and Fab fragments of antibody D1.3 on antigen binding.
Bhat TN; Bentley GA; Fischmann TO; Boulot G; Poljak RJ
Nature; 1990 Oct; 347(6292):483-5. PubMed ID: 2215663
[TBL] [Abstract][Full Text] [Related]
13. Human combinatorial Fab library yielding specific and functional antibodies against the human fibroblast growth factor receptor 3.
Rauchenberger R; Borges E; Thomassen-Wolf E; Rom E; Adar R; Yaniv Y; Malka M; Chumakov I; Kotzer S; Resnitzky D; Knappik A; Reiffert S; Prassler J; Jury K; Waldherr D; Bauer S; Kretzschmar T; Yayon A; Rothe C
J Biol Chem; 2003 Oct; 278(40):38194-205. PubMed ID: 12842902
[TBL] [Abstract][Full Text] [Related]
14. Neutralisation and binding of VHS virus by monovalent antibody fragments.
Cupit PM; Lorenzen N; Strachan G; Kemp GJ; Secombes CJ; Cunningham C
Virus Res; 2001 Dec; 81(1-2):47-56. PubMed ID: 11682124
[TBL] [Abstract][Full Text] [Related]
15. Selection of binders from phage displayed antibody libraries using the BIAcore biosensor.
Malmborg AC; Dueñas M; Ohlin M; Söderlind E; Borrebaeck CA
J Immunol Methods; 1996 Oct; 198(1):51-7. PubMed ID: 8914596
[TBL] [Abstract][Full Text] [Related]
16. Comparative thermodynamic analyses of the Fv, Fab* and Fab fragments of anti-dansyl mouse monoclonal antibody.
Shimba N; Torigoe H; Takahashi H; Masuda K; Shimada I; Arata Y; Sarai A
FEBS Lett; 1995 Mar; 360(3):247-50. PubMed ID: 7883041
[TBL] [Abstract][Full Text] [Related]
17. Comparative interaction kinetics of two recombinant Fabs and of the corresponding antibodies directed to the coat protein of tobacco mosaic virus.
Chatellier J; Rauffer-Bruyère N; Van Regenmortel MH; Altschuh D; Weiss E
J Mol Recognit; 1996; 9(1):39-51. PubMed ID: 8723318
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a recombinant humanized anti-cocaine monoclonal antibody and its Fab fragment.
Kirley TL; Norman AB
Hum Vaccin Immunother; 2015; 11(2):458-67. PubMed ID: 25692880
[TBL] [Abstract][Full Text] [Related]
19. Structural and functional characterization of a monoclonal antibody specific for the preS1 region of hepatitis B virus.
Pizarro JC; Vulliez-le Normand B; Riottot MM; Budkowska A; Bentley GA
FEBS Lett; 2001 Dec; 509(3):463-8. PubMed ID: 11749974
[TBL] [Abstract][Full Text] [Related]
20. Critical contribution of VH-VL interaction to reshaping of an antibody: the case of humanization of anti-lysozyme antibody, HyHEL-10.
Nakanishi T; Tsumoto K; Yokota A; Kondo H; Kumagai I
Protein Sci; 2008 Feb; 17(2):261-70. PubMed ID: 18227432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
